WCWoo Jae Cho

Woo Jae Cho

*This is an algorithmically generated author record based on publicly available information.

Woo Jae Cho has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical evaluation of a functional diet containing Siraitia grosvenorii residual extract for atopic dermatitis in dogs: a self-controlled study

    by Mi-Kyung Park, Jihee Hong, Woo Jae Cho, Kun-Ho Song

    Canine atopic dermatitis (CAD) is a chronic inflammatory skin disease that significantly impairs quality of life. Nutritional interventions have gained attention as supportive therapeutic strategies. This study investigated the clinical efficacy and safety of a functional diet containing Siraitia grosvenorii residual extract by evaluating its effects on clinical symptoms and inflammatory markers in dogs with CAD using a self-controlled design. A total of 32 dogs diagnosed with CAD were fed a standard diet for 12 weeks (control phase) followed by a functional diet for 12 weeks (treatment phase). Clinical assessments, including transepidermal water loss (TEWL), Canine Atopic Dermatitis Extent and Severity Index (CADESI-04), Pruritus Visual Analog Scale (PVAS), Owner Global Assessment of Treatment Efficacy (OGATE), and serum IgE levels were conducted at baseline and at 6-week intervals. TEWL, CADESI-04, and PVAS scores significantly improved during the treatment phase compared with the control phase (p = 0.0002, < 0.0001, and < 0.0001, respectively). No significant difference was observed in serum in serum IgE levels (p = 0.8046). The OGATE responses indicated 80.65% rate of owner-reported satisfaction. The functional diet significantly improved the clinical signs of CAD and was well tolerated. These findings suggest that nutritional support with the Siraitia grosvenorii extract may be a beneficial adjunctive therapy for CAD.


  • Open Access

    Effects of Synbiotic Preparation Containing Lactobacillus gasseri BNR17 on Body Fat in Obese Dogs: A Pilot Study

    by Han-Joon Lee, Jae Hyoung Cho, Woo-Jae Cho, Seong-Ho Gang, Seung-Hwan Park, Bong-Jun Jung, Hyeun Bum Kim, Kun Ho Song

    Obesity is an important health concern in humans and dogs. It can cause a variety of secondary problems, including low bacterial diversity. Several approaches have been tried to solve this problem; one of them is probiotic supplementation. Lactobacillus gasseri BNR17 is derived from breast milk and has been proven to be effective for obesity in humans. However, there have been no studies using a synbiotic preparation containing L. gasseri BNR17 for obesity management in dogs. Therefore, the present study evaluated the effectiveness of a synbiotic preparation containing L. gasseri BNR17 in reducing body fat in obese dogs. A group of obese dogs were fed a synbiotic preparation for 10 weeks. Obesity variables included body weight, body condition score, subcutaneous fat thickness, subcutaneous fat mass and proportion of the fat mass. In addition, feces collected at 0-week and 10-week time points were analyzed for the intestinal microbiome. Results showed a significant decrease in body weight, body condition score, and subcutaneous fat mass and proportion at the level of the third lumbar vertebra. Diversity and functional analysis of the microbiota in obese dogs showed increased microbial diversity, and increased abundance of metabolism of carbohydrate, and lipid after supplementation with a synbiotic preparation. This study was conducted as a pilot study, and the results demonstrated that a synbiotic preparation containing L. gasseri BNR17 may play a role in reducing body fat and resolving the obesity in dogs.